More stories >

Julie: Mitral Valve Prolapse

April 10, 2024

Julie is a mother of four—she spends her time supporting her family, playing piano, biking and baking. Soon after having her youngest son, Julie discovered she had premature ventricular contractions. Several years later, her condition progressed to ventricular tachycardia, which can be a dangerous heart rhythm if left untreated. Listen to Julie's story to find out how she's doing today.

Give the Gift of Hope

4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background

Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.